Homepage Post #1
MEET OUR DOCTORS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
QUESTIONS? GET IN TOUCH:
News from The American Academy of Ophthalmology
- Deep Learning Model Detects Macular Diseases Across Multiple OCT Imaging Systems April 20, 2026A model trained on macular scans from the Spectralis OCT system was able to reliably identify macular diseases using novel scans taken with either the Spectralic or Cirrus OCT systems.
- Week in Review: HRT and Risk of Glaucoma, Postsurgical IOL Dislocation, Systemic Medications Associated With Uveitis April 17, 2026Taking hormone replacement therapy in the postmenopausal period may increase glaucoma risk, several factors may cause an IOL to dislocate after surgery, and high rates of uveitis are seen with certain systemic medications.
- The Phase of Thyroid Eye Disease May Be a Consideration When Starting Teprotumumab April 17, 2026A recent study found that in patients with thyroid eye disease (TED) who relapse, receiving teprotumumab during the active phase, vs during the stable phase, appeared to lead to a more severe and prolonged disease relapse course.
- Greater Control of Refractory Noninfectious Uveitis Is Seen With Weekly vs Biweekly Adalimumab April 16, 2026Patients whose refractory noninfectious uveitis was poorly controlled with biweekly adalimumab had improved outcomes when the dosage was increased to once weekly.